(Q46863548)

English

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

1 reference

based on heuristic

inferred from title

Joseph Biederman

4

object named as

Joseph Biederman

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

1

object named as

Sharon B Wigal

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Scott H Kollins

8

object named as

Scott H Kollins

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

author name string

James J McGough

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

James T McCracken

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Thomas J Spencer

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Kelly L Posner

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Tim L Wigal

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Tanya M Clark

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

David A Mays

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Yuxin Zhang

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Simon J Tulloch

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

publication date

1 August 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Journal of Attention Disorders

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

275-289

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Stimulant medications

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Psychotropic practice patterns for youth: a 10-year perspective

1 reference

https://api.crossref.org/works/10.1177%2F1087054705281121

21 January 2018

Identifiers

10.1177/1087054705281121

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16371674

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46863548&oldid=2135216236"